BioSpace News Archive

Deerfield Management and ARCH Venture Partners have partnered with venture capital firm Section 32 to sponsor DA32 Life Science Tech Acquisition Corp, a blank check company that is today priced for $200 million in an initial public offering (IPO).

The medical beds market was valued at US$ 3,580.52 million in 2018 and it is projected to reach US$ 5,710.7 million in 2027; it is expected to grow at a CAGR of 5.4% from 2019 to 2027.

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations including Takeda, Origin Therapeutics, ERS Genomics and more.

Ring Therapeutics hopes to bring in a “new era of gene therapies” to rise above the challenges of current options. A cohort of investors bought into the hope with a $117 million Series B funding round.

The FDA Watch List considers drug-resistant Candida auris (C. auris) an urgent threat, drug-resistant Candida species a serious threat, and azole-resistant Aspergillus Fumigatus worth watching – especially since person-to-person transmission of drug-resistant fungi has been recently documented.

RELIEF THERAPEUTICS Holding AG announced that it has closed a definitive agreement to acquire all outstanding shares of AdVita Lifescience GmbH, a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and diagnosis of rare lung diseases.

RELIEF THERAPEUTICS Holding AG reported that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., reported in a press release yesterday that the Nation of Georgia’s Prime Minister and Minister of Health have issued an Emergency Use Authorization for intravenous aviptadil for the treatment of critical COVID-19.

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the first batch of subjects in its phase I clinical trial of GT20029 in China.

Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced the appointment of Dr. Mark J. Gilbert as Chair of its Scientific Advisory Board – leading a team of cell and gene therapeutics experts as scientific advisors to the company.

Vacuum concentration is the method used for gentle drying, evaporation, purification, and preservation of thermally sensitive materials.